SynopsisIt is a vesicular monoamine transporter 2 inhibitor which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia. Global Deutetrabenazine API market is projected to reach US$ million in 2029, increasing from US$ m.....
SynopsisIt is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy The global Dextroamphetamine Sulfate API market was valued at US$ million .....
SynopsisIt is a medication used to treat low blood sugar due to a number of specific causes. The global Diazoxide API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024.....
SynopsisIt is an amide local anesthetic The global Dibucaine(Cinchocaine) API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical m.....
SynopsisIt is a medication used in the treatment of filariasis including lymphatic filariasis, tropical pulmonary eosinophilia, and loiasis. Global Diethylcarbamazine Citrate API market is projected to reach US$ million in 2029, increasing from US$ million in 20.....
Synopsis Amfepramone, also known as diethylpropion, is a stimulant drug of the phenethylamine, amphetamine, and cathinone classes that is used as an appetite suppressant Highlights
SynopsisIt is a nucleoside transport inhibitor and a PDE3 inhibitor medication that inhibits blood clot formation The global Dipyridamole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the .....
SynopsisIt is a stimulant drug of the morpholine chemical class used as an appetite suppressant The global Phendimetrazine Tartrate market was valued at US$ 320 million in 2023 and is anticipated to reach US$ 450.3 million by 2030, witnessing a CAGR of 5.0% duri.....
SynopsisIt is a stimulant drug which is used as an appetite suppressant The global Mazindol Tablet market was valued at US$ 420 million in 2023 and is anticipated to reach US$ 636.2 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030......
SynopsisDoxapram hydrochloride (marketed as Dopram, Stimulex or Respiram) is a respiratory stimulant. The global Doxapram Hydrochloride Injection market was valued at US$ 910 million in 2023 and is anticipated to reach US$ 13110 million by 2030, witnessing a CAG.....
